Drug Patents owned by Ipr

1. List of Crestor drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6858618

(Pediatric)

IPR Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
Jun, 2022

(7 months ago)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) May 27, 2023

Drugs and Companies using ROSUVASTATIN CALCIUM ingredient

Market Authorisation Date: 12 August, 2003

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of CRESTOR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in